enzh-TWfrdeitjaptrues

The Dana-Farber Bing Center for Waldenstrom's Macroglobulinemia Web site is intended to provide general information about the program, its care and research programs, and about Waldenstrom's Macroglobulinemia and related diseases. This site also provides links to health information that may be written by Dana-Farber staff or by outside providers, and access (links) to some external Web sites for your convenience. The Dana-Farber Waldenstrom's Macroglobulinemia Program is not responsible for the availability, accuracy, or content of these external sites, nor does it endorse them.

No Medical Advice Given
This site is not an attempt to practice medicine or provide specific medical advice, nor does the use of the site establish a doctor-patient relationship. For medical treatment or answers to personal questions, we strongly encourage you to consult with a qualified health care provider. For advice about your own care, please ask your doctor!

Restrictions on Use
You assume full responsibility for using the information on this site, and you understand and agree that the Dana-Farber Waldenstrom's Macroglobulinemia Program is not responsible or liable for any claim, loss, or damage resulting from its use. While we try to keep the information on the site as accurate as possible, we disclaim any warranty concerning its accuracy, timeliness, and completeness, and any other warranty, express or implied, including warranties of merchantability or fitness for a particular purpose. The Dana-Farber Waldenstrom's Macroglobulinemia Program also does not warrant that access to the site will be error- or virus-free.

Copyright Infringement
Material on the Dana-Farber Waldenstrom's Macroglobulinemia Program Web site is protected by copyright law. Unless otherwise stated, users may print or download information from this site for personal, non-commercial use only. Permission to reprint or otherwise reproduce any document in whole or in part is prohibited, unless prior written consent is obtained from the copyright owner.

Latest Bing Center News

27th Annual IWMF Virtual Educational Forum, August 27-28, 2022

27th Annual IWMF Virtual Educational Forum, August 27-28, 2022

The 27th Annual IWMF Educational Forum provides a unique opportunity to learn and connect with and from one another. The 2022 Virtual Ed Forum brings WM specialists, clinicians, researchers, patients, and caregivers together. A two-day program features pertinent and timely information related to symptoms and complications of WM, current treatment options, new therapies, and life topics that align with this year’s Ed Forum theme:  Living, Learning, and Thriving with WM. This year’s Educational Forum will conclude with our popular “Ask the Doctors” question-and-answer session.

Read more..

“Grand Rounds” with Dr. Steven Treon

“Grand Rounds” with Dr. Steven Treon

A project that has been a long time in the making came to fruition earlier this year.  The goal of the WMFC was to have a series of video conferences led by key WM researchers, and to specifically invite Canadian Medical Professionals to learn more about our disease from those who know it best.

Read more..

When to Wait and When to Treat - Shayna Sarosiek, MD

When to Wait and When to Treat - Shayna Sarosiek, MD

Rare Cancers Updates offers a dynamic half-day online learning experience aimed at helping clinicians efficiently gain valuable education on a rare topic. You'll have the opportunity to earn CME credits and compete for amazing prizes during our 2022 Contest! Join us during the June 17th meeting, where you'll gain insights and practical guidance on Waldenström Macroglobulinemia. Registration is free!

Read more..

Young WM International Support Group Meeting Monday, May 16th at 7:15PM U.S. ET

Young WM International Support Group Meeting Monday, May 16th at 7:15PM U.S. ET

WM patients and caregivers under the age of 50:Join the Young WM International Support Group on May 16th with special guest, Dr. Shayna Sarosiek!

Read more..

Waldenstrom’s Macroglobulinemia (WM): Treatment Progress Workshop

Waldenstrom’s Macroglobulinemia (WM): Treatment Progress Workshop

Workshop Date and Time: Wednesday, May 25, 2022, 1:30 – 2:30 pm, Eastern Time. Registrants can listen in live over the phone or online as a webcast. Click below to learn more or register for this workshop.

Read more..

IWMF Torch April, 2022 - Bing Neel Syndrome, Dr. Jorge Castillo

IWMF Torch April, 2022 - Bing Neel Syndrome, Dr. Jorge Castillo

In this issue of the IWMF Torch, Dr. Jorge Castillo reviews the disgnosis, indications to treat, and treatment options for Bing Neel Syndrome (BNS) in patients with WM, as these have a direct impact on further understanding the choices available to manage BNS.

Read more..

Covid Antibodies, CAR-T & More. Can We Feel Hopeful this Spring?

Covid Antibodies, CAR-T & More. Can We Feel Hopeful this Spring?

Our IWMF Support Group Leaders and International Affiliates had the pleasure of meeting with Dr. Shayna Sarosiek of Dana-Farber Cancer Institute this week. Dr. Sarosiek covered many topics, including Evusheld, CAR-T therapy, and WM treatments on the horizon. This is a fabulous and timely presentation you don't want to miss!

Read more..

Waldenström Macroglobulinemia Treatment Decisions: What’s Right for You?

Waldenström Macroglobulinemia Treatment Decisions: What’s Right for You?

When faced with a WM diagnosis, what determines the best treatment for YOU? In this 30-minute webinar, Dr. Jorge Castillo will review key factors that affect treatment decisions, emerging treatment research, and tips for partnering with your healthcare team.

Read more..

Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma Treatment Regimens

Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma Treatment Regimens

Cancer therapy selection, dosing, administration, and the management of related adverse events can be a complex process that should be handled by an experienced health care team. Clinicians must choose and verify treatment options based on the individual patient; drug dose modifications and supportive care interventions should be administered accordingly. The cancer treatment regimens below may include both U.S. Food and Drug Administration-approved and unapproved indications/regimens. These regimens are provided only to supplement the latest treatment strategies.

Read more..

Living Well with Waldenstrom's Macroglobulinemia (FREE WEBINAR)

Living Well with Waldenstrom's Macroglobulinemia (FREE WEBINAR)

This program is designed to provide attendees with essential information that  will help you participate more actively and confidently in decisions about your  Waldenström Macroglobulinemia treatment and survivorship.

Read more..